Rekha Chaudhuri

6PUBLICATIONS
65CO-AUTHORS
Respiratory diseasesTranslational and applied bioinformaticsMajor global burdens of diseaseGene expression (incl. microarray and other genome-wide approaches)Reaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 19, 2025
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT.

Graham Devereux, Seonaidh Cotton, Mintu Nath

|May 05, 2023
Definitions of non-response and response to biological therapy for severe asthma: a systematic review.

Ekaterina Khaleva, Anna Rattu, Chris Brightling

|Dec 22, 2022
Identifying and appraising outcome measures for severe asthma: a systematic review.

Anna Rattu, Ekaterina Khaleva, Chris Brightling

|May 13, 2022
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.

P Jane McDowell, John Busby, Catherine E Hanratty

|Jun 15, 2021
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma.

Simon Couillard, Rahul Shrimanker, Rekha Chaudhuri

|Jul 26, 2019
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.

Graham Devereux, Seonaidh Cotton, Shona Fielding

Pageof 1